24/7 Wall St.146d agoneutral
A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers SquibbNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.159d agoneutral
Assessing Bristol Myers Squibb (BMY) Valuation As Shares Track Mixed Returns And Earnings OutlookPharmaceutical Technology165d agoneutral
Kardigan targets IPO to support cardiology pipeline progressionReuters172d agoneutral
Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discoveryThe Wall Street Journal172d agoneutral
Bristol-Myers Squibb Brings Anthropic’s Claude to 30,000 of Its StaffThe Wall Street Journal180d agoneutral
Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-UpThe Wall Street Journal180d agoneutral
Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-Up